<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_virome" title="Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness" shortTitle="virome" author="Ratanesh  K. Seth, Rabia Maqsood, Ayan Mondal, Dipro Bose, Diana Kimono, LaRinda  A. Holland, Patricia Janulewicz Lloyd, Nancy Klimas, Ronnie  D. Horner, Kimberly Sullivan, Efrem  S. Lim, Saurabh Chatterjee" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1999-4915/11/10/968/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
4.	LS	4.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
The	DT	the
well-characterized	JJ	well-characterized
GWI	NNP	GWI
symptoms	NNS	symptom
are	VBP	be
GI	NN	GI
inflammatory	JJ	inflammatory
disease	NN	disease
,	,	,
chronic	JJ	chronic
fatigue	NN	fatigue
,	,	,
neuroinflammation	NN	neuroinflammation
,	,	,
and	CC	and
cognitive	JJ	cognitive
impairment	NN	impairment
.	.	.
</s>
<s type="decl">
The	DT	the
current	JJ	current
study	NN	study
investigates	VBZ	investigate
a	DT	a
mechanistic	JJ	mechanistic
analysis	NN	analysis
of	IN	of
the	DT	the
gut	NN	gut
virome-bacteriome	NN	virome-bacteriome
mediated	VBN	mediate
GI	NN	GI
and	CC	and
neuroinflammation	NN	neuroinflammation
.	.	.
</s>
<s type="decl">
To	IN	to
our	PRP$	our
knowledge	NN	knowledge
,	,	,
this	DT	this
is	VBZ	be
the	DT	the
first	JJ	first
study	NN	study
that	WDT	that
examined	VBD	examine
GW	NNP	GW
chemical-induced	JJ	chemical-induced
virome	NN	virome
dysbiosis	NN	dysbiosis
and	CC	and
bacteriome-virome	NN	bacteriome-virome
interactions	NNS	interaction
in	IN	in
GWI	NNP	GWI
.	.	.
</s>
<s type="decl">
In	IN	in
our	PRP$	our
previous	JJ	previous
study	NN	study
,	,	,
we	PRP	we
have	VBP	have
shown	VBN	show
that	IN	that
GW	NNP	GW
chemical	JJ	chemical
exposure	NN	exposure
causes	VBZ	cause
bacterial	JJ	bacterial
dysbiosis	NN	dysbiosis
and	CC	and
that	DT	that
led	VBD	lead
to	IN	to
the	DT	the
loss	NN	loss
of	IN	of
healthy	JJ	healthy
gut	NN	gut
bacteria	NNS	bacteria
such	JJ	such
as	IN	as
Lactobacillus	NNP	Lactobacillus
and	CC	and
Bifidobacterium	NNP	Bifidobacterium
.	.	.
</s>
<s type="decl">
Gut	NN	gut
dysbiosis	NN	dysbiosis
induced	VBN	induce
leaky	JJ	leaky
gut	NN	gut
symptoms	NNS	symptom
and	CC	and
systemic	JJ	systemic
inflammation	NN	inflammation
in	IN	in
GWI	NNP	GWI
.	.	.
</s>
<s type="decl">
In	IN	in
a	DT	a
recent	JJ	recent
review	NN	review
,	,	,
it	PRP	it
has	VBZ	have
been	VBN	be
reported	VBN	report
that	IN	that
gut	NN	gut
virome	NN	virome
is	VBZ	be
the	DT	the
missing	JJ	miss
link	NN	link
between	IN	between
bacterial	JJ	bacterial
dysbiosis	NN	dysbiosis
and	CC	and
host	NN	host
immunity	NN	immunity
.	.	.
</s>
<s type="decl">
The	DT	the
same	JJ	same
study	NN	study
also	RB	also
described	VBD	describe
the	DT	the
role	NN	role
of	IN	of
virome	NN	virome
in	IN	in
TLR	NNP	TLR
signaling	NN	signaling
and	CC	and
GI	NNP	GI
diseases	NNS	disease
and	CC	and
hence	RB	hence
concluding	VBG	conclude
that	IN	that
virome	NN	virome
analysis	NN	analysis
may	MD	may
lead	VB	lead
to	IN	to
a	DT	a
novel	JJ	novel
therapeutic	JJ	therapeutic
strategy	NN	strategy
for	IN	for
GI	NNP	GI
complications	NNS	complication
.	.	.
</s>
<s type="decl">
The	DT	the
above	JJ	above
study	NN	study
prompted	VBD	prompt
us	PRP	we
to	TO	to
explore	VB	explore
the	DT	the
role	NN	role
of	IN	of
enteric	JJ	enteric
viruses	NNS	virus
in	IN	in
GWI	NNP	GWI
pathology	NN	pathology
and	CC	and
as	IN	as
a	DT	a
probable	JJ	probable
therapeutic	JJ	therapeutic
target	NN	target
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
,	,	,
we	PRP	we
found	VBD	find
that	IN	that
the	DT	the
GW	NNP	GW
chemical	JJ	chemical
exposure	NN	exposure
led	VBD	lead
to	IN	to
an	DT	a
increase	NN	increase
in	IN	in
virome	JJ	virome
richness	NN	richness
and	CC	and
relative	JJ	relative
abundance	NN	abundance
of	IN	of
dsDNA	NNP	dsDNA
bacteriophages	NNS	bacteriophage
<hi rend="italic">
Myoviridae	NNP	Myoviridae
</hi>
,	,	,
<hi rend="italic">
Siphoviridae	NNP	Siphoviridae
</hi>
,	,	,
and	CC	and
<hi rend="italic">
Caudovirales	NNPS	Caudovirale
</hi>
and	CC	and
decreased	VBD	decrease
relative	JJ	relative
abundance	NN	abundance
of	IN	of
ssDNA	NNP	SsDNA
bacteriophages	NNS	bacteriophage
<hi rend="italic">
Microviridae	NNP	Microviridae
</hi>
.	.	.
</s>
<s type="decl">
We	PRP	we
used	VBD	use
a	DT	a
broad-spectrum	JJ	broad-spectrum
antiviral	JJ	antiviral
compound	NN	compound
Ribavirin	NNP	Ribavirin
to	TO	to
test	VB	test
the	DT	the
hypothesis	NN	hypothesis
that	IN	that
(	-LRB-	(
a	CD	a
)	-RRB-	)
inhibition	NN	inhibition
of	IN	of
gut	NN	gut
viruses	NNS	virus
in	IN	in
the	DT	the
host	NN	host
may	MD	may
prove	VB	prove
the	DT	the
role	NN	role
of	IN	of
gut	NN	gut
virome	NN	virome
in	IN	in
GWI	NNP	GWI
and	CC	and
(	-LRB-	(
b	CD	b
)	-RRB-	)
antiviral	JJ	antiviral
treatment	NN	treatment
may	MD	may
help	VB	help
to	TO	to
reconstruct	VB	reconstruct
and	CC	and
restore	VB	restore
the	DT	the
virome	NN	virome
signature	NN	signature
in	IN	in
GWI	NNP	GWI
.	.	.
</s>
<s type="decl">
Ribavirin	NNP	Ribavirin
has	VBZ	have
been	VBN	be
extensively	RB	extensively
used	VBN	use
as	IN	as
a	DT	a
therapeutic	JJ	therapeutic
drug	NN	drug
in	IN	in
several	JJ	several
viral	JJ	viral
infections	NNS	infection
including	VBG	include
Paramyxovirus	NNP	Paramyxovirus
,	,	,
Adenovirus	NNP	Adenovirus
,	,	,
and	CC	and
RSV	NNP	RSV
infections	NNS	infection
.	.	.
</s>
<s type="decl">
Our	PRP$	our
results	NNS	result
showed	VBD	show
that	IN	that
Ribavirin	NNP	Ribavirin
reverses	VBZ	reverse
GWI-induced	VBN	gWI-induce
alterations	NNS	alteration
of	IN	of
the	DT	the
enteric	JJ	enteric
viral	JJ	viral
community	NN	community
.	.	.
</s>
<s type="decl">
The	DT	the
enteric	JJ	enteric
bacteriophage-bacteria	NN	bacteriophage-bacteria
(	-LRB-	(
parasite-host	NN	parasite-host
)	-RRB-	)
interaction	NN	interaction
is	VBZ	be
an	DT	a
essential	JJ	essential
phenomenon	NN	phenomenon
to	TO	to
regulate	VB	regulate
both	CC	both
bacterial	JJ	bacterial
and	CC	and
viral	JJ	viral
community	NN	community
in	IN	in
the	DT	the
gut	NN	gut
and	CC	and
play	VB	play
as	IN	as
a	DT	a
key	JJ	key
role	NN	role
in	IN	in
gut	NN	gut
health	NN	health
.	.	.
</s>
<s type="decl">
Here	RB	here
,	,	,
we	PRP	we
found	VBD	find
an	DT	a
independent	JJ	independent
or	CC	or
cumulative	JJ	cumulative
effect	NN	effect
of	IN	of
both	CC	both
virome	NN	virome
and	CC	and
bacteriome	NN	bacteriome
dysbiosis	NN	dysbiosis
in	IN	in
weakening	VBG	weaken
of	IN	of
GI	NNP	GI
tight	JJ	tight
junctions	NNS	junction
(	-LRB-	(
increased	VBN	increase
Claudin-2	NNP	Claudin-2
and	CC	and
decreased	VBD	decrease
ZO1	NNP	ZO1
and	CC	and
Occludin	NNP	Occludin
)	-RRB-	)
,	,	,
GI	NNP	GI
inflammation	NN	inflammation
(	-LRB-	(
increased	VBN	increase
MCP1	NN	MCP1
and	CC	and
IL6	NN	IL6
)	-RRB-	)
,	,	,
systemic	JJ	systemic
inflammation	NN	inflammation
(	-LRB-	(
increased	VBN	increase
serum	NN	serum
IFNγ	NN	IFNγ
and	CC	and
IL6	NN	IL6
)	-RRB-	)
and	CC	and
neuroinflammation	NN	neuroinflammation
(	-LRB-	(
increased	VBN	increase
microglia	NN	microglia
activation	NN	activation
and	CC	and
brain	NN	brain
IL6	NN	IL6
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
present	JJ	present
study	NN	study
also	RB	also
showed	VBD	show
that	IN	that
Ribavirin	NNP	Ribavirin
treatment	NN	treatment
improved	VBD	improve
GI	NNP	GI
tight	JJ	tight
junction	NN	junction
assembly	NN	assembly
and	CC	and
subsequently	RB	subsequently
decreasing	VBG	decrease
GI	NN	GI
and	CC	and
neuroinflammation	NN	neuroinflammation
.	.	.
</s>
<s type="decl">
Interestingly	RB	interestingly
,	,	,
inducing	VBG	induce
gut	NN	gut
sterility	NN	sterility
by	IN	by
using	VBG	use
antibiotics	NNS	antibiotics
also	RB	also
improves	VBZ	improve
such	JJ	such
GI	NN	GI
and	CC	and
neurological	JJ	neurological
complications	NNS	complication
.	.	.
</s>
<s type="decl">
Results	NNS	result
reported	VBD	report
here	RB	here
are	VBP	be
also	RB	also
strongly	RB	strongly
supported	VBN	support
by	IN	by
previous	JJ	previous
such	JJ	such
studies	NNS	study
where	WRB	where
Ribavirin	NNP	Ribavirin
or	CC	or
antibiotics	NNS	antibiotics
were	VBD	be
applied	VBN	apply
as	IN	as
therapeutics	NNS	therapeutics
in	IN	in
other	JJ	other
GI	NN	GI
complications	NNS	complication
and	CC	and
neurological	JJ	neurological
illnesses	NNS	illness
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
nonavailability	NN	nonavailability
of	IN	of
germ-free	JJ	germ-free
and	CC	and
gnotobiotic	JJ	gnotobiotic
mice	NNS	mouse
or	CC	or
mice	NNS	mouse
completely	RB	completely
devoid	JJ	devoid
of	IN	of
gut	NN	gut
viruses	NNS	virus
prove	VBP	prove
to	TO	to
be	VB	be
a	DT	a
serious	JJ	serious
handicap	NN	handicap
in	IN	in
establishing	VBG	establish
the	DT	the
exact	JJ	exact
role	NN	role
of	IN	of
viruses	NNS	virus
in	IN	in
GWI	NNP	GWI
or	CC	or
any	DT	any
other	JJ	other
disease	NN	disease
pathology	NN	pathology
though	IN	though
use	NN	use
of	IN	of
antiviral	JJ	antiviral
cocktails	NNS	cocktail
similar	JJ	similar
to	IN	to
our	PRP$	our
approach	NN	approach
have	VBP	have
been	VBN	be
shown	VBN	show
to	TO	to
serve	VB	serve
the	DT	the
purpose	NN	purpose
.	.	.
</s>
</p>
<p>
<s type="decl">
Gut	NN	gut
microbiome	NN	microbiome
is	VBZ	be
a	DT	a
collection	NN	collection
of	IN	of
trillions	NNS	trillion
of	IN	of
microorganisms	NNS	microorganism
that	WDT	that
modulated	VBD	modulate
host	NN	host
pathology	NN	pathology
and	CC	and
physiology	NN	physiology
through	IN	through
different	JJ	different
mechanisms	NNS	mechanism
.	.	.
</s>
<s type="decl">
Previous	JJ	previous
reports	NNS	report
have	VBP	have
suggested	VBN	suggest
that	IN	that
the	DT	the
intestinal	JJ	intestinal
microbiota	NN	microbiota
had	VBD	have
a	DT	a
strong	JJ	strong
influence	NN	influence
on	IN	on
the	DT	the
mucosal	JJ	mucosal
immune	JJ	immune
system	NN	system
and	CC	and
vice	RB	vice
versa	RB	versa
.	.	.
</s>
<s type="decl">
A	DT	a
balanced	JJ	balanced
pathogen	NN	pathogen
and	CC	and
commensal	JJ	commensal
microbiome	NN	microbiome
composition	NN	composition
maintain	VBP	maintain
the	DT	the
microbiome-host	NN	microbiome-host
immune	JJ	immune
homeostasis	NN	homeostasis
.	.	.
</s>
<s type="sub">
However	RB	however
,	,	,
any	DT	any
alteration	NN	alteration
in	IN	in
the	DT	the
microbiome	NN	microbiome
may	MD	may
activate	VB	activate
innate	JJ	innate
and	CC	and
adaptive	JJ	adaptive
immune	JJ	immune
responses	NNS	response
and	CC	and
may	MD	may
progress	VB	progress
to	IN	to
an	DT	a
inflammatory	JJ	inflammatory
phenotype	NN	phenotype
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
we	PRP	we
have	VBP	have
shown	VBN	show
that	IN	that
the	DT	the
GW	NNP	GW
chemical-induced	JJ	chemical-induced
virome	NN	virome
richness	NN	richness
and	CC	and
dysbiosis	NN	dysbiosis
showed	VBD	show
a	DT	a
strong	JJ	strong
association	NN	association
with	IN	with
activated	VBN	activate
Toll-like	NNP	Toll-like
receptor-7	NN	receptor-7
(	-LRB-	(
TLR7	NNP	TLR7
)	-RRB-	)
and	CC	and
TLR9	NNP	TLR9
mediated	VBN	mediate
proinflammatory	JJ	proinflammatory
pathways	NNS	pathway
.	.	.
</s>
<s type="decl">
We	PRP	we
also	RB	also
found	VBD	find
that	IN	that
the	DT	the
expression	NN	expression
and	CC	and
activation	NN	activation
of	IN	of
downstream	JJ	downstream
signaling	VBG	signal
molecules	NNS	molecule
including	VBG	include
TLR7-MyD88	NNP	TLR7-MyD88
(	-LRB-	(
binding	NN	binding
of	IN	of
TLR7	NNP	TLR7
with	IN	with
adaptor	NN	adaptor
molecule	NN	molecule
myosin	NN	myosin
D88	FW	D88
)	-RRB-	)
,	,	,
TLR9-MyD88	NNP	TLR9-MyD88
,	,	,
or	CC	or
TLR4-Flottilin	NNP	TLR4-Flottilin
(	-LRB-	(
localization	NN	localization
of	IN	of
TLR4	NNP	TLR4
in	IN	in
lipid	NN	lipid
raft	NN	raft
)	-RRB-	)
complex	JJ	complex
formation	NN	formation
,	,	,
TRAF6	NNP	Traf6
,	,	,
IKK-α	NNP	IKK-α
,	,	,
and	CC	and
p65	NN	p65
(	-LRB-	(
NFκB	NN	nfκb
activation	NN	activation
)	-RRB-	)
have	VBP	have
been	VBN	be
increased	VBN	increase
upon	IN	upon
gut	NN	gut
virome	NN	virome
and	CC	and
microbiome	NN	microbiome
dysbiosis	NN	dysbiosis
.	.	.
</s>
<s type="decl">
The	DT	the
dysbiosis	NN	dysbiosis
was	VBD	be
also	RB	also
accompanied	VBN	accompany
by	IN	by
increased	VBN	increase
inflammation	NN	inflammation
while	IN	while
use	NN	use
of	IN	of
Ribavirin	NNP	Ribavirin
or	CC	or
antibiotics	NNS	antibiotics
independently	RB	independently
downregulated	VBD	downregulate
these	DT	this
pathways	NNS	pathway
and	CC	and
subsequently	RB	subsequently
inflammation	NN	inflammation
.	.	.
</s>
<s type="decl">
The	DT	the
above	JJ	above
results	NNS	result
prompted	VBD	prompt
us	PRP	we
to	TO	to
study	VB	study
whether	IN	whether
virome	NN	virome
diversity	NN	diversity
had	VBD	have
a	DT	a
direct	JJ	direct
connection	NN	connection
to	IN	to
a	DT	a
sustained	VBN	sustain
systemic	JJ	systemic
inflammatory	JJ	inflammatory
response	NN	response
via	IN	via
increased	VBN	increase
serum	NN	serum
IL6	NN	IL6
or	CC	or
vice	RB	vice
versa	RB	versa
.	.	.
</s>
<s type="decl">
We	PRP	we
found	VBD	find
that	IN	that
IL6	NNP	IL6
and	CC	and
virome	NN	virome
diversity	NN	diversity
had	VBD	have
a	DT	a
positive	JJ	positive
correlation	NN	correlation
in	IN	in
GWI	NNP	GWI
.	.	.
</s>
<s type="decl">
Studies	NNS	Study
have	VBP	have
shown	VBN	show
that	IN	that
the	DT	the
enteric	JJ	enteric
viruses	NNS	virus
can	MD	can
activate	VB	activate
TLR3	NNP	TLR3
signaling	NN	signaling
pathway	NN	pathway
to	TO	to
induce	VB	induce
anti-inflammatory	JJ	anti-inflammatory
response	NN	response
via	IN	via
IFNβ	NNP	IFNβ
production	NN	production
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
it	PRP	it
has	VBZ	have
always	RB	always
been	VBN	be
a	DT	a
conflict	NN	conflict
whether	IN	whether
viral-induced	JJ	viral-induced
TLR3	NN	TLR3
activation	NN	activation
leads	VBZ	lead
to	IN	to
pro-	JJ	pro-
or	CC	or
anti-inflammatory	JJ	anti-inflammatory
response	NN	response
in	IN	in
viral	JJ	viral
pathogenesis	NN	pathogenesis
.	.	.
</s>
<s type="decl">
In	IN	in
our	PRP$	our
study	NN	study
,	,	,
we	PRP	we
observed	VBD	observe
that	IN	that
increased	VBN	increase
TLR3	NNP	TLR3
might	MD	might
switch	VB	switch
to	IN	to
pro-inflammatory	JJ	pro-inflammatory
response	NN	response
via	IN	via
IL6	NNP	IL6
or	CC	or
fail	VB	fail
to	TO	to
produce	VB	produce
significant	JJ	significant
IFNβ	NNP	IFNβ
in	IN	in
order	NN	order
to	TO	to
support	VB	support
its	PRP$	its
anti-inflammatory	JJ	anti-inflammatory
role	NN	role
in	IN	in
GWI	NNP	GWI
though	IN	though
such	JJ	such
mechanisms	NNS	mechanism
in	IN	in
the	DT	the
host	NN	host
remain	VBP	remain
inconclusive	JJ	inconclusive
at	IN	at
this	DT	this
time	NN	time
.	.	.
</s>
</p>
</text>